Director, Texas Children’s Cancer and Hematology Centers
Elise C. Young Professor of Pediatric Oncology
Department of Pediatrics,
Baylor College of Medicine
Texas Children’s Hospital
Dan L. Duncan Cancer Center
Baylor College of Medicine
1102 Bates Street, Suite 1570
Houston, TX 77030
Dr. David Poplack has served as the Director of Texas Children’s Cancer and Hematology Centers since 1993. He is Deputy Director of Baylor College of Medicine’s Dan L. Duncan Cancer Center; Section Head, Hematology/Oncology, Department of Pediatrics, BCM; Hematology/Oncology Service Chief, Texas Children’s Hospital; and is the Elise C. Young Professor of Pediatric Oncology.
Dr. Poplack is a graduate of Tufts University. He received his M.D. degree from Boston University School of Medicine, completed his pediatric internship at Stanford University, his residency in pediatrics at the Children’s Hospital in Boston, and his fellowship in pediatric hematology-oncology at the National Cancer Institute in Bethesda, Maryland.
He is internationally recognized as a leader in the field of pediatric cancer.
Dr. Poplack has authored more than 365 original articles and book chapters in the field of pediatric oncology. He is co-editor of Principles and Practice of Pediatric Oncology, the leading textbook of pediatric oncology, which is in its seventh edition.
Dr. Poplack is Principal Investigator of an NCI K12 Pediatric Oncology Clinical Research Training Grant and serves on the editorial board of numerous subspecialty journals.
He is also the developer of the Passport For Care, an interactive website that addresses the need to provide long-term survivors of childhood cancer and their caregivers with screening guidelines and resources individualized to the survivor’s treatment history.
Dr. Poplack has served on many national and international committees, including panel appointments at the National Institutes of Health, the Food and Drug Administration (FDA) and the Institute of Medicine and a term as an appointed member of the National Cancer Institute’s Board of Scientific Counselors. In 2016, Dr. Poplack was awarded the American Society of Pediatric Hematology-Oncology Distinguished Career Award.
MD, Boston University School of Medicine
Internship, Stanford University Hospital
Residency, Children’s Hospital Medical Center, Boston
Fellowship, National Cancer Institute
Diplomate, American Board of Pediatrics
Certified Sub-specialty, American Board of Pediatrics — Hematology/Oncology
American Association for the Advancement of Science (AAAS)
American Association for Cancer Research (AACR)
American Medical Association (AMA)
American Society for Clinical Investigation (ASCI)
American Society of Clinical Oncology (ASCO)
American Society of Hematology (ASH)
International Society of Paediatric Oncology (SIOP)
Texas Medical Association (TMA)
Pizzo PA, Poplack DG: Principles and Practice of Pediatric Oncology (Seventh edition) Philadelphia, PA: Lippincott Williams & Wilkins, 2015.
Blaney SM, Heideman, R., Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM. Phase I clinical trial of Intrathecal Topetecan in patients with neoplastic meningitis. Journal of Clinical Oncology 2003, 21: 143-147.
Margolin, JF and Poplack, DG. Review of article “What is the optimal therapy for childhood AML? Oncology 2002, 1069-1070.
Steuber CP and Poplack DG. Acute Lymphoblastic Leukemia. In Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ (eds). Rudolph’s Pediatrics, 21st Edition. New York. McGraw-Hill Medical Publishing Division, pp. 1594-1600, 2002.
Bomgaars L, Chamberlain MC, Poplack DG and Blaney M. Leptomeningeal metastases. In Levin VA (ed). Cancer in the Nervous System, Second Edition. New York. Oxford University Press, pp. 375-396, 2002.